1. Home
  2. NSPR vs RGS Comparison

NSPR vs RGS Comparison

Compare NSPR & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$0.72

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$27.93

Market Cap

72.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
RGS
Founded
2005
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
72.0M
IPO Year
2009
1994

Fundamental Metrics

Financial Performance
Metric
NSPR
RGS
Price
$0.72
$27.93
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
157.0K
3.6K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.24
EPS
N/A
0.89
Revenue
$2,310,000.00
$210,134,000.00
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
N/A
P/E Ratio
N/A
$30.81
Revenue Growth
N/A
3.52
52 Week Low
$0.69
$18.23
52 Week High
$2.93
$31.50

Technical Indicators

Market Signals
Indicator
NSPR
RGS
Relative Strength Index (RSI) 28.77 49.65
Support Level N/A $26.06
Resistance Level $1.04 $28.51
Average True Range (ATR) 0.09 0.83
MACD -0.00 -0.07
Stochastic Oscillator 5.72 56.91

Price Performance

Historical Comparison
NSPR
RGS

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

Share on Social Networks: